WallStSmart
LONA

LeonaBio, Inc.

NASDAQ: LONA · HEALTHCARE · BIOTECHNOLOGY

$11.00
-4.32% today

Updated 2026-06-03

Market cap
$77.22M
P/E ratio
P/S ratio
EPS (TTM)
$-24.09
Dividend yield
52W range
$3 – $14
Volume
0.0M

WallStSmart proprietary scores

29
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
7.3
Quality
B+
3.0
Profitability
D
5.0
Valuation
C+
2/9
Piotroski F-Score
Weak
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$18.00
+63.64%
12-Month target
Intrinsic (DCF)
Margin of safety
1 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-20.90M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-95.64M$-117.67M$-96.94M$-105.61M$-32.95M
EPS$-24.09
Free cash flow$-73.61M$-101.06M$-97.20M$-45.73M$-20.90M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
LONA$77.22M294.33.05.07.3Avoid
LLY$948.95B7810.010.05.06.0Strong Buy
JNJ$536.54B594.79.03.36.0-71.41%Buy
ABBV$380.57B634.08.04.05.0-55.64%Buy
UNH$343.21B545.35.54.75.5-26.61%Buy
MRK$285.64B503.38.02.75.0-49.34%Hold

Smart narrative

LeonaBio, Inc. trades at $11.00. Our Smart Value Score of 29/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is LeonaBio, Inc.'s stock price?

LeonaBio, Inc. (LONA) trades at $11.00.

Is LeonaBio, Inc. overvalued?

LeonaBio, Inc. carries a Smart Value Score of 29/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of LeonaBio, Inc. (LONA)?

The 12-month analyst consensus target is $18.00, about 63.6% above the current $11.00. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-298.80%
Beta1.98
50D MA$9.60
200D MA$6.18
Shares out0.01B
Float0.01B
Short ratio
Avg volume0.0M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years